$AMGN
AMGEN INC

2024 Q2 Form 10-Q Financial Statement

#000031815424000020 Filed on May 03, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q1
Revenue $8.388B $7.447B $6.105B
YoY Change 20.07% 21.98% -2.13%
Cost Of Revenue $3.236B $3.200B $1.720B
YoY Change 78.49% 86.05% 10.19%
Gross Profit $5.152B $4.247B $4.385B
YoY Change -0.41% -3.15% -6.24%
Gross Profit Margin 61.42% 57.03% 71.83%
Selling, General & Admin $1.785B $1.808B $1.258B
YoY Change 37.94% 43.72% 2.44%
% of Gross Profit 34.65% 42.57% 28.69%
Research & Development $1.447B $1.343B $1.058B
YoY Change 30.01% 26.94% 10.32%
% of Gross Profit 28.09% 31.62% 24.13%
Depreciation & Amortization $1.400B $1.399B $900.0M
YoY Change 56.25% 55.44% 7.02%
% of Gross Profit 27.17% 32.94% 20.52%
Operating Expenses $3.232B $3.151B $2.316B
YoY Change 34.28% 36.05% 5.9%
Operating Profit $1.909B $991.0M $1.921B
YoY Change -28.87% -48.41% -23.16%
Interest Expense -$1.206B -$824.0M -$543.0M
YoY Change 60.37% 51.75% 84.07%
% of Operating Profit -63.17% -83.15% -28.27%
Other Income/Expense, Net -$307.0M -$235.0M $2.064B
YoY Change -3.46% -111.39% -489.43%
Pretax Income $794.0M -$68.00M $3.442B
YoY Change -50.81% -101.98% 105.49%
Income Tax $48.00M $45.00M $601.0M
% Of Pretax Income 6.05% 17.46%
Net Earnings $746.0M -$113.0M $2.841B
YoY Change -45.9% -103.98% 92.48%
Net Earnings / Revenue 8.89% -1.52% 46.54%
Basic Earnings Per Share $1.39 -$0.21 $5.32
Diluted Earnings Per Share $1.38 -$0.21 $5.28
COMMON SHARES
Basic Shares Outstanding 536.4M shares 535.9M shares 534.0M shares
Diluted Shares Outstanding 541.0M shares 536.0M shares 538.0M shares

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $9.301B $9.708B $31.60B
YoY Change -72.8% -69.28% 382.9%
Cash & Equivalents $9.301B $9.708B $31.60B
Short-Term Investments $1.000M
Other Short-Term Assets $2.976B $2.821B $2.395B
YoY Change 28.06% 17.79% -3.74%
Inventory $7.995B $8.724B $5.011B
Prepaid Expenses
Receivables $6.934B $6.776B $5.736B
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $27.21B $28.03B $44.70B
YoY Change -42.58% -37.3% 141.38%
LONG-TERM ASSETS
Property, Plant & Equipment $6.097B $6.002B $5.460B
YoY Change 10.21% 9.93% 6.18%
Goodwill $18.62B $18.57B $15.53B
YoY Change 19.86% 19.57% 4.26%
Intangibles $30.17B $31.37B $15.39B
YoY Change 106.19% 103.81% 5.67%
Long-Term Investments
YoY Change
Other Assets $8.816B $9.007B $7.633B
YoY Change 22.56% 18.0% 25.75%
Total Long-Term Assets $63.70B $64.95B $44.02B
YoY Change 48.53% 47.56% 8.21%
TOTAL ASSETS
Total Short-Term Assets $27.21B $28.03B $44.70B
Total Long-Term Assets $63.70B $64.95B $44.02B
Total Assets $90.91B $92.98B $88.72B
YoY Change 0.71% 4.8% 49.87%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.267B $1.628B $1.320B
YoY Change 87.05% 23.33% -5.92%
Accrued Expenses $13.72B $14.13B $12.06B
YoY Change 0.03% 17.13% 13.37%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $5.528B $3.959B $834.0M
YoY Change 155.1% 374.7% -1.18%
Total Short-Term Liabilities $21.52B $19.71B $14.22B
YoY Change 25.85% 38.68% 10.31%
LONG-TERM LIABILITIES
Long-Term Debt $57.12B $60.06B $60.76B
YoY Change -3.81% -1.15% 68.73%
Other Long-Term Liabilities $2.363B $2.357B $2.532B
YoY Change -6.82% -6.91% -7.32%
Total Long-Term Liabilities $59.48B $62.42B $63.29B
YoY Change -3.93% -1.38% 63.37%
TOTAL LIABILITIES
Total Short-Term Liabilities $21.52B $19.71B $14.22B
Total Long-Term Liabilities $59.48B $62.42B $63.29B
Total Liabilities $81.00B $82.13B $77.51B
YoY Change 2.51% 5.97% 50.13%
SHAREHOLDERS EQUITY
Retained Earnings -$27.12B -$27.87B -$26.92B
YoY Change 6.2% 3.53% -8.96%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $5.925B $5.022B $5.348B
YoY Change
Total Liabilities & Shareholders Equity $90.91B $92.98B $88.72B
YoY Change 0.71% 4.8% 49.87%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q1
OPERATING ACTIVITIES
Net Income $746.0M -$113.0M $2.841B
YoY Change -45.9% -103.98% 92.48%
Depreciation, Depletion And Amortization $1.400B $1.399B $900.0M
YoY Change 56.25% 55.44% 7.02%
Cash From Operating Activities $2.459B $689.0M $1.064B
YoY Change -40.16% -35.24% -50.83%
INVESTING ACTIVITIES
Capital Expenditures $238.0M $230.0M $344.0M
YoY Change -12.18% -33.14% 81.05%
Acquisitions
YoY Change
Other Investing Activities $21.00M -$13.00M -$28.00M
YoY Change -65.0% -53.57% -40.43%
Cash From Investing Activities -$217.0M -$217.0M $1.358B
YoY Change 2.84% -115.98% -1323.42%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $0.00 $704.0M
YoY Change -100.0%
Cash From Financing Activities -2.649B -$1.708B $21.51B
YoY Change 118.93% -107.94% -712.09%
NET CHANGE
Cash From Operating Activities 2.459B $689.0M $1.064B
Cash From Investing Activities -217.0M -$217.0M $1.358B
Cash From Financing Activities -2.649B -$1.708B $21.51B
Net Change In Cash -407.0M -$1.236B $23.93B
YoY Change -115.14% -105.16% -1737.99%
FREE CASH FLOW
Cash From Operating Activities $2.459B $689.0M $1.064B
Capital Expenditures $238.0M $230.0M $344.0M
Free Cash Flow $2.221B $459.0M $720.0M
YoY Change -42.13% -36.25% -63.53%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Investment Type Extensible Enumeration
InvestmentTypeExtensibleEnumeration
http://fasb.org/srt/2023#PartnershipInterestMember
CY2024Q1 us-gaap Investment Type Extensible Enumeration
InvestmentTypeExtensibleEnumeration
http://fasb.org/srt/2023#PartnershipInterestMember
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7447000000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6105000000 usd
CY2024Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3200000000 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1720000000 usd
CY2024Q1 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
1343000000 usd
CY2023Q1 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
1058000000 usd
CY2024Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1808000000 usd
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1258000000 usd
CY2024Q1 amgn Other General Expense Income Other Adjustments
OtherGeneralExpenseIncomeOtherAdjustments
105000000 usd
CY2023Q1 amgn Other General Expense Income Other Adjustments
OtherGeneralExpenseIncomeOtherAdjustments
148000000 usd
CY2024Q1 us-gaap Costs And Expenses
CostsAndExpenses
6456000000 usd
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
4184000000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
991000000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
1921000000 usd
CY2024Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
824000000 usd
CY2023Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
543000000 usd
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-235000000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2064000000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-68000000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
3442000000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
45000000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
601000000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-113000000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
2841000000 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.21
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
5.32
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.21
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
5.28
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
536000000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
534000000 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
536000000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
538000000 shares
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-113000000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
2841000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-24000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
28000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
126000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
-86000000 usd
CY2024Q1 amgn Other Comprehensive Income Loss Other Gains Losses Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossOtherGainsLossesNetOfTaxPortionAttributableToParent
-3000000 usd
CY2023Q1 amgn Other Comprehensive Income Loss Other Gains Losses Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossOtherGainsLossesNetOfTaxPortionAttributableToParent
21000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
99000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-37000000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-14000000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2804000000 usd
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9708000000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10944000000 usd
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6776000000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
7268000000 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
8724000000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
9518000000 usd
CY2024Q1 us-gaap Other Assets Current
OtherAssetsCurrent
2821000000 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
2602000000 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
28029000000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
30332000000 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6002000000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5941000000 usd
CY2024Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
31372000000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
32641000000 usd
CY2024Q1 us-gaap Goodwill
Goodwill
18570000000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
18629000000 usd
CY2024Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
9007000000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
9611000000 usd
CY2024Q1 us-gaap Assets
Assets
92980000000 usd
CY2023Q4 us-gaap Assets
Assets
97154000000 usd
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
1628000000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1590000000 usd
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
14127000000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
15359000000 usd
CY2024Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
3959000000 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
1443000000 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
19714000000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
18392000000 usd
CY2024Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
60061000000 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
63170000000 usd
CY2024Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
1862000000 usd
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
2354000000 usd
CY2024Q1 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
3964000000 usd
CY2023Q4 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
4680000000 usd
CY2024Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2357000000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2326000000 usd
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
2750000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
2750000000 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
536400000 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
535400000 shares
CY2024Q1 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
33082000000 usd
CY2023Q4 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
33070000000 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-27870000000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-26549000000 usd
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-190000000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-289000000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
5022000000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
6232000000 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
92980000000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
97154000000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
6232000000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-113000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
99000000 usd
CY2024Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
2.25
CY2024Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
1208000000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
34000000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
103000000 usd
CY2024Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
125000000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
5022000000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
3661000000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
2841000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-37000000 usd
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
2.13
CY2023Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
1138000000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
11000000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
47000000 usd
CY2023Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
37000000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
5348000000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-113000000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
2841000000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1399000000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
900000000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
103000000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
47000000 usd
CY2024Q1 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-401000000 usd
CY2023Q1 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-49000000 usd
CY2024Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
27000000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
31000000 usd
CY2024Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-515000000 usd
CY2023Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
1830000000 usd
CY2024Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
95000000 usd
CY2023Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
60000000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-486000000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
144000000 usd
CY2024Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-806000000 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
58000000 usd
CY2024Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
89000000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
139000000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
23000000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-253000000 usd
CY2024Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
223000000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
443000000 usd
CY2024Q1 amgn Increase Decrease In Noncurrent Tax Liability
IncreaseDecreaseInNoncurrentTaxLiability
-715000000 usd
CY2023Q1 amgn Increase Decrease In Noncurrent Tax Liability
IncreaseDecreaseInNoncurrentTaxLiability
107000000 usd
CY2024Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1054000000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-230000000 usd
CY2024Q1 amgn Increase Decrease In Sales Incentives And Allowance
IncreaseDecreaseInSalesIncentivesAndAllowance
-316000000 usd
CY2023Q1 amgn Increase Decrease In Sales Incentives And Allowance
IncreaseDecreaseInSalesIncentivesAndAllowance
-402000000 usd
CY2024Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-56000000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-78000000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
689000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1064000000 usd
CY2024Q1 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
0 usd
CY2023Q1 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
1124000000 usd
CY2024Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
0 usd
CY2023Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
550000000 usd
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
230000000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
344000000 usd
CY2024Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-13000000 usd
CY2023Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-28000000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-217000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1358000000 usd
CY2024Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
23798000000 usd
CY2024Q1 us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
410000000 usd
CY2023Q1 us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
420000000 usd
CY2024Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 usd
CY2023Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
704000000 usd
CY2024Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
1208000000 usd
CY2023Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
1137000000 usd
CY2024Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-90000000 usd
CY2023Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-28000000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1708000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
21509000000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1236000000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
23931000000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10944000000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7629000000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9708000000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
31560000000 usd
CY2024Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of estimates</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Actual results may differ from those estimates.</span></div>
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
9900000000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
9800000000 usd
CY2024Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7447000000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6105000000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
45000000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
601000000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-68000000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
3442000000 usd
CY2024Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.662
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.175
CY2024Q1 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
40000000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-113000000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
2841000000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
536000000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
534000000 shares
CY2024Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2023Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
4000000 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
536000000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
538000000 shares
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.21
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
5.32
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.21
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
5.28
CY2024Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
9237000000 usd
CY2024Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0 usd
CY2024Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
0 usd
CY2024Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
9237000000 usd
CY2023Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
10404000000 usd
CY2023Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0 usd
CY2023Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
0 usd
CY2023Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
10404000000 usd
CY2024Q1 us-gaap Cash
Cash
471000000 usd
CY2023Q4 us-gaap Cash
Cash
540000000 usd
CY2024Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
50000000 usd
CY2023Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
5000000 usd
CY2024Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
928000000 usd
CY2023Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
993000000 usd
CY2024Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
5270000000 usd
CY2023Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
5747000000 usd
CY2024Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
2526000000 usd
CY2023Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
2778000000 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
8724000000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
9518000000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
18629000000 usd
CY2024Q1 us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
-49000000 usd
CY2024Q1 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-10000000 usd
CY2024Q1 us-gaap Goodwill
Goodwill
18570000000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
55080000000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
24858000000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
30222000000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
55229000000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
23806000000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
31423000000 usd
CY2024Q1 amgn Identifiable Intangible Assets Gross
IdentifiableIntangibleAssetsGross
56230000000 usd
CY2024Q1 amgn Identifiable Intangible Assets Accumulated Amortization
IdentifiableIntangibleAssetsAccumulatedAmortization
24858000000 usd
CY2024Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
31372000000 usd
CY2023Q4 amgn Identifiable Intangible Assets Gross
IdentifiableIntangibleAssetsGross
56447000000 usd
CY2023Q4 amgn Identifiable Intangible Assets Accumulated Amortization
IdentifiableIntangibleAssetsAccumulatedAmortization
23806000000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
32641000000 usd
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1200000000 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
693000000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
3600000000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
4500000000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
3900000000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
3900000000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
2900000000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
2200000000 usd
CY2024Q1 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
1404000000 usd
CY2023Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
1420000000 usd
CY2024Q1 us-gaap Hedged Liability Fair Value Hedge Cumulative Increase Decrease
HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease
-363000000 usd
CY2023Q4 us-gaap Hedged Liability Fair Value Hedge Cumulative Increase Decrease
HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease
-314000000 usd
CY2024Q1 us-gaap Other Long Term Debt
OtherLongTermDebt
33000000 usd
CY2023Q4 us-gaap Other Long Term Debt
OtherLongTermDebt
17000000 usd
CY2024Q1 us-gaap Long Term Debt
LongTermDebt
64020000000 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
64613000000 usd
CY2024Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
3959000000 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
1443000000 usd
CY2024Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
60061000000 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
63170000000 usd
CY2024Q1 us-gaap Extinguishment Of Debt Amount
ExtinguishmentOfDebtAmount
410000000 usd
CY2024Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
133000000 usd
CY2024Q1 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
7000000000 usd
CY2024Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
2.25
CY2023Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
2.25
CY2024Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
2.25
CY2024Q1 us-gaap Equity Securities Fvni Noncurrent
EquitySecuritiesFVNINoncurrent
3985000000 usd
CY2024Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
13447000000 usd
CY2024Q1 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
96000000 usd
CY2024Q1 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
1168000000 usd
CY2023Q4 us-gaap Equity Securities Fvni Noncurrent
EquitySecuritiesFVNINoncurrent
4514000000 usd
CY2023Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
15063000000 usd
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
96000000 usd
CY2023Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
1188000000 usd
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
96000000 usd
CY2022Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
270000000 usd
CY2024Q1 amgn Business Combination Contingent Consideration Arrangements Payments
BusinessCombinationContingentConsiderationArrangementsPayments
2000000 usd
CY2023Q1 amgn Business Combination Contingent Consideration Arrangements Payments
BusinessCombinationContingentConsiderationArrangementsPayments
2000000 usd
CY2024Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
2000000 usd
CY2023Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
5000000 usd
CY2024Q1 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
96000000 usd
CY2023Q1 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
273000000 usd
CY2024Q1 us-gaap Notes Payable Fair Value Disclosure
NotesPayableFairValueDisclosure
57800000000 usd
CY2023Q4 us-gaap Notes Payable Fair Value Disclosure
NotesPayableFairValueDisclosure
59200000000 usd
CY2024Q1 us-gaap Long Term Debt
LongTermDebt
64000000000 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
64600000000 usd
CY2024Q1 us-gaap Maximum Length Of Time Foreign Currency Cash Flow Hedge
MaximumLengthOfTimeForeignCurrencyCashFlowHedge
P3Y
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-235000000 usd
CY2024Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
824000000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2064000000 usd
CY2023Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
543000000 usd
CY2024Q1 us-gaap Foreign Currency Cash Flow Hedge Gain Loss To Be Reclassified During Next12 Months
ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months
97000000 usd
CY2024Q1 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
225000000 usd
CY2024Q1 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
1072000000 usd
CY2023Q4 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
145000000 usd
CY2023Q4 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
1092000000 usd
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000318154-24-000020-index-headers.html Edgar Link pending
0000318154-24-000020-index.html Edgar Link pending
0000318154-24-000020.txt Edgar Link pending
0000318154-24-000020-xbrl.zip Edgar Link pending
amgn-20240331.htm Edgar Link pending
amgn-20240331.xsd Edgar Link pending
amgn-ex31_20240331x10xq.htm Edgar Link pending
amgn-ex32_20240331x10xq.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
amgn-20240331_def.xml Edgar Link unprocessable
amgn-20240331_lab.xml Edgar Link unprocessable
amgn-20240331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
amgn-20240331_htm.xml Edgar Link completed
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
amgn-20240331_cal.xml Edgar Link unprocessable